18 results
F-1
EX-10.13
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
in strict accordance with the requirements.
(3) Party A shall provide Party B with the necessary education and training on occupational technology, safety … and health, rules and regulations, etc., and Party B shall seriously participate in the various necessary education and training organized by Party
DRS/A
EX-10.5
CNTB
Connect Biopharma Holdings Ltd
26 Jan 21
Draft registration statement (amended)
12:00am
in any filings made by the parties with the Securities and Exchange Commission or as otherwise required by law.
6.4 Training. Company hereby represents … and warrants that within the last [***] days, it has conducted a training session for all Company Representatives that may have access to Confidential
F-1
EX-10.5
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
in any filings made by the parties with the Securities and Exchange Commission or as otherwise required by law.
6.4 Training. Company hereby represents … and warrants that within the last [***] days, it has conducted a training session for all Company Representatives that may have access to Confidential
F-1
EX-10.14
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
that information which is generally known and used by persons with training and experience comparable to your own, which is common knowledge in the industry
20-F
2021 FY
EX-4.11
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
an obligation of confidentiality. Rather, you will be expected to use only that information which is generally known and used by persons with training
20-F
EX-4.10
gpdmq
31 Mar 22
Annual report (foreign)
4:33pm
F-1/A
EX-99.1
k8r17ziq82l9yu78uzfd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
DRS/A
bve59kp7rdn6 luf
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
4yhvuxonrq 461wrlbsp
17 Dec 20
Draft registration statement
12:00am
424B4
rggdjtxhy72n7b0
19 Mar 21
Prospectus supplement with pricing info
4:49pm
6-K
lvo6hjsejl4jitpesfx
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
F-1
mat6ftzrz 8wo7kdv
26 Feb 21
Registration statement (foreign)
4:56pm
20-F
pe31k9eajme7cl
31 Mar 22
Annual report (foreign)
4:33pm
F-1/A
1m48 ztgxgtcp056nszv
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
20-F
EX-4.13
rasp5welzq2rxznjucr3
31 Mar 22
Annual report (foreign)
4:33pm
F-1/A
3wtfeksmw3pm2zch
18 Mar 21
Registration statement (foreign) (amended)
6:15am
- Prev
- 1
- Next